Browse by UCL people
Group by: Type | Date
Number of items: 7.
Article
Balendra, R;
Moens, TG;
Isaacs, AM;
(2017)
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies.
EMBO Molecular Medicine
, 9
(7)
, Article e201707848. 10.15252/emmm.201707848.
|
Matarin, M;
Perona, M;
Salih, DA;
Yasvoina, M;
Cummings, DM;
Liu, W;
NahabooSolim, MA;
... Smith, KJ; + view all
(2015)
A Genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology.
Cell Reports
, 10
(4)
633 - 645.
10.1016/j.celrep.2014.12.041.
|
Mizielinska, S;
Grönke, S;
Niccoli, T;
Ridler, CE;
Clayton, EL;
Devoy, A;
Moens, T;
... Isaacs, AM; + view all
(2014)
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins.
Science
10.1126/science.1256800.
|
Moens, TG;
Mizielinska, S;
Niccoli, T;
Mitchell, JS;
Thoeng, A;
Ridler, CE;
Grönke, S;
... Isaacs, AM; + view all
(2018)
Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD.
Acta Neuropathologica
, 135
(3)
pp. 445-457.
10.1007/s00401-017-1798-3.
|
Moens, TG;
Partridge, L;
Isaacs, AM;
(2017)
Genetic models of C9orf72: What is toxic?
Current Opinion in Genetics and Development
, 44
pp. 92-101.
10.1016/j.gde.2017.01.006.
|
Simone, R;
Balendra, R;
Moens, TG;
Preza, E;
Wilson, KM;
Heslegrave, A;
Woodling, NS;
... Isaacs, AM; + view all
(2018)
G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo.
EMBO Molecular Medicine
, 10
(1)
pp. 22-31.
10.15252/emmm.201707850.
|
Thesis
Moens, Thomas Grover;
(2018)
Molecular mechanisms of pathogenesis in Drosophila models of C9orf72 mutation associated ALS/FTD.
Doctoral thesis (Ph.D), UCL (University College London).
|